Clarivate Epidemiology’s coverage of diabetic retinopathy (DR) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of DR for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the remaining countries covered in this report.
Clarivate Epidemiology’s DR forecast will answer the following questions:
- Of all people with DR, how many in each of the major mature pharmaceutical markets are diagnosed?
- Of all people with DR, how many in each of the major mature pharmaceutical markets are drug-treated?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of DR over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.
Clarivate Epidemiology provides at least 10 years of forecast data for the following DR patient populations:
- Total prevalent cases of DR.
- Total prevalent cases of proliferative DR.
- Total prevalent cases of nonproliferative DR.
- Total prevalent cases of nonproliferative DR by severity subtype.
- Dx prevalent cases of severe nonproliferative DR.
- Dx prevalent cases of proliferative DR.
- Drug-treated prevalent cases of severe nonproliferative DR.
- Drug-treated prevalent cases of proliferative DR.
Note: Coverage may vary by country and region.
Saayali Khankari
Saayali Khankari, B.D.S, M.P.H., Epidemiologist, Epidemiology. Prior to joining Clarivate, Ms. Khankari worked as a clinical trial associate for a pharmaceutical company focusing on infectious disease and Phase III clinical trials. Ms. Khankari also worked as a research assistant analyzing qualitative data for multiple ongoing research studies at Boston Medical Center. She holds a master’s degree in public health with a major in epidemiology and biostatistics from Boston University and a bachelor’s degree in dental surgery.
Sunali D. Goonesekera, S.M.
Sunali D. Goonesekera, S.M., Senior Manager, Epidemiology. Prior to joining Clarivate, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.